Hamai Y, Fujii T, Yamashita T, et al. Peripheral blood mononuclear cells from women with recurrent abortion exhibit an aberrant reaction to release cytokines upon the direct contact of human leukocyte antigen-G-expressing cells. Am J Reprod Immunol 1998;40:408–413.
211.
Kanai T, Fujii T, Unno N, et al. Human leukocyte antigen-Gexpressing cells differently modulate the release of cytokines from mononuclear cells present in the decidua versus peripheral blood. Am J Reprod Immunol 2001;45:94–99.
212.
Jenkins C, Roberts J, Wilson R, et al. Evidence of a T(H) 1 type response associated with recurrent miscarriage. Fertil Steril 2000;73:1206–1208.
213.
Schust DJ, Hill JA. Correlation of serum cytokine and adhesion molecule determinations with pregnancy outcome. J Soc Gynecol Investig 1996;3:259–261.
214.
Chen JR, Cheng JG, Shatzer T, et al. Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation but is not essential for subsequent embryogenesis. Endocrinology 2000;141:4365–4372.
215.
Stewart CL, Kaspar P, Brunet LJ, et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992;359:76–79.
216.
Billington WD, Davies M, Bell SC. Maternal antibody to foetal histocompatibility and trophoblast-specific antigens. Ann Immunol (Paris) 1984;135D:331–335.
217.
Sargent IL, Wilkins T, Redman CW. Maternal immune responses to the fetus in early pregnancy and recurrent miscarriage. Lancet 1988;2:1099–1104.
218.
Tafuri A, Alferink J, M¨oller P, et al. T cell awareness of paternal alloantigens during pregnancy. Science 1995;270:630–633.
219.
Bermas BL, Hill JA. Proliferative responses to recall antigens are associated with pregnancy outcome in women with a history of recurrent spontaneous abortion. J Clin Invest 1997;100:1330–1334.
220.
Grossman C. Possible underlying mechanisms of sexual dimorphism in the immune response, fact and hypothesis. J Steroid Biochem 1989;34:241–251.
221.
Runnebaum B, Stober I, Zander J. Progesterone, 20 alphadihydroprogesterone and 20 beta-dihydroprogesterone in mother and child at birth. Acta Endocrinol (Copenh) 1975;80:569–576.
222.
Siiteri PK, Febres F, Clemens LE, et al. Progesterone and maintenance of pregnancy: is progesterone nature’s immunosuppressant? Ann N Y Acad Sci 1977;286:384–397.
223.
Ehring GR, Kerschbaum HH, Eder C, et al. A nongenomic mechanism for progesterone-mediated immunosuppression: inhibition of K+ channels, Ca2+ signaling, and gene expression in T lymphocytes. J Exp Med 1998;188:1593–1602.
224.